GlaxoSmithKline recalls Alli weight loss product in the US and Puerto Rico

Defects found in tamper-evident seals and labelling

GlaxoSmithKline (GSK) is recalling all supplies of its weight loss drug Alli in the US and Puerto Rico after customers reported finding other tablets and capsules in some bottles.

The UK drug company said some packages had tamper-evident seals that were not authentic and some bottles inside the outer carton were missing labels.

GSK is now conducting an investigation and working with the US Food and Drug Administration (FDA) on the recall.

'Safety is our first priority and we are asking retailers and pharmacies to remove all Alli from their shelves immediately,' said Colin Mackenzie, President Consumer Healthcare North America.

Alli is a turquoise blue capsule with a dark blue band imprinted with the text '60 Orlistat'. It is packaged in a labelled bottle that has an inner foil seal imprinted with the words: 'Sealed for Your Protection'. Pictures of the product are available on the website at www.myalli.com.

'We are committed to finding out what happened and to doing everything possible to prevent future issues with Alli,' added Mackenzie. 'We regret any inconvenience caused by this retailer recall.'

Companies